Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21146205 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting VELCADE-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) Incorporated Into Double Autotransplantation for Untreated Multiple Myeloma (MM)
Condition: Multiple Myeloma
Interventions: Drug: Velcade;   Drug: Thalidomide;   Drug: Dexamethasone;   Procedure: Peripheral Blood Stem Cell (PBSC) collection;   Procedure: First Autologous Transplantation;   Procedure: Second Autologous Transplantation

Indicates status has not been verified in more than two years